Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE WIMMER : revenue, balance sheet and financial ratios

PHARMACIE WIMMER is a French company founded 16 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LYON (69007), this company of category PME shows in 2015 a revenue of 1.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE WIMMER (SIREN 513318956)
Indicator 2025 2024 2023 2022 2021 2020 2019 2017 2016 2015
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C 1 487 032 €
Net income 426 798 € 17 666 € -194 228 € 55 061 € -174 584 € 42 091 € 91 981 € 169 830 € 107 772 € -182 196 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C -80 755 €
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C -12.3%

Revenue and income statement

In 2025, PHARMACIE WIMMER generates positive net income of 427 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

426 798 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 103%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 48%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

103.171%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

47.664%

Solvency indicators evolution
PHARMACIE WIMMER

Sector positioning

Debt ratio
103.17 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average -8 pts over 3 years

In 2025, the debt ratio of PHARMACIE WIMMER (103.17) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
47.66% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average +18 pts over 3 years

In 2025, the financial autonomy of PHARMACIE WIMMER (47.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 3038.71. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

3038.711

Liquidity indicators evolution
PHARMACIE WIMMER

Sector positioning

Liquidity ratio
3038.71 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent +45 pts over 3 years

In 2025, the liquidity ratio of PHARMACIE WIMMER (3038.71) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE WIMMER

Positioning of PHARMACIE WIMMER in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE WIMMER is estimated at 6 779 736 € (range 4 600 761€ - 10 638 340€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
4600k€ 6779k€ 10638k€
6 779 736 € Range: 4 600 761€ - 10 638 340€
NAF 5 année 2025

Valuation method used

Net Income Multiple
426 798 € × 15.9x = 6 779 737 €
Range: 4 600 762€ - 10 638 341€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE WIMMER with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE WIMMER

What is the revenue of PHARMACIE WIMMER ?

The revenue of PHARMACIE WIMMER in 2015 is 1.5 M€.

Is PHARMACIE WIMMER profitable?

Yes, PHARMACIE WIMMER generated a net profit of 427 k€ in 2025.

Where is the headquarters of PHARMACIE WIMMER ?

The headquarters of PHARMACIE WIMMER is located in LYON (69007), in the department Rhone.

Where to find the tax return of PHARMACIE WIMMER ?

The tax return of PHARMACIE WIMMER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE WIMMER operate?

PHARMACIE WIMMER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.